Poly Adenosine Diphosphate-Ribose Polymerase (PARP) Inhibitors in Pancreatic Cancer

Pancreatic cancer is the third most common cause of cancer death in the United States and eleventh worldwide. The majority of patients present with advanced disease with five-year overall survival of less than 10%. Traditional chemotherapy has been the mainstay treatment for years, with limited impr...

Descripción completa

Detalles Bibliográficos
Autores principales: Sunkara, Tejasvi, Bandaru, Sai Samyuktha, Boyilla, Rajendra, Kunadharaju, Rajesh, Kukkadapu, Prithvi, Chennamadhavuni, Adithya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8879621/
https://www.ncbi.nlm.nih.gov/pubmed/35228986
http://dx.doi.org/10.7759/cureus.22575

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8879621/
https://www.ncbi.nlm.nih.gov/pubmed/35228986
http://dx.doi.org/10.7759/cureus.22575

Ejemplares similares